This HTML5 document contains 57 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q63337348
rdf:type
wikibase:Item
schema:description
клінічне випробування կլինիկական փորձարկում clinical trial klinisch onderzoek ensayu clínicu
rdfs:label
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephr
skos:prefLabel
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephr
schema:name
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephr
p:P1476
wds:Q63337348-95B0AC35-9428-42C9-BE53-8B9997B46B42
wdt:P1476
A Double-Blind, Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) (Triple Reuptake Inhibitor Anti-Depressant Effects - TRIADE Study)
p:P582
wds:Q63337348-38BC9C29-4869-4D4E-A794-E92ADD866286
wdt:P582
2013-02-01T00:00:00Z
p:P31
wds:Q63337348-F47CE3C0-2AA3-47DB-818F-7DC12B05DBEE
wdt:P31
wd:Q30612
p:P580
wds:Q63337348-30F9F6D9-822D-4773-A73F-FCE3BCF2B39F
wdt:P580
2011-02-01T00:00:00Z
p:P17
wds:Q63337348-F7D72B7F-3345-4227-A2DB-A42CC9E27B34
wdt:P17
wd:Q30
p:P6153
wds:Q63337348-2EB1CE43-ABE8-486E-9476-4D6F25773D9F wds:Q63337348-2863E88F-4E70-48F7-94EA-7996D9849C87 wds:Q63337348-7F531937-B66C-4781-A8E9-46622EED36D7 wds:Q63337348-4C2D823C-3D65-4329-825D-C2946F20BFEB wds:Q63337348-733DA4CD-DC50-492E-B069-F02BA2AB967C wds:Q63337348-E95422AB-DC75-4DB7-93BE-A6DA196A3977 wds:Q63337348-BF6AFD5B-2499-4339-BBFA-473A6F449AED wds:Q63337348-CC3DB1CA-5063-49AD-94DA-01D5CE00916F
wdt:P6153
wd:Q30298472 wd:Q1950740 wd:Q30269522 wd:Q2303536 wd:Q49117 wd:Q5025432 wd:Q7914455 wd:Q6518847
p:P4844
wds:Q63337348-005BE6CF-C7D6-4BD3-9099-CE102734B9D3 wds:Q63337348-79B11D9B-0837-4950-A379-FFE814D0A1C3 wds:Q63337348-C346D870-CBC2-45D3-9957-501C4BDF8542 wds:Q63337348-DFC0841B-9901-4EE6-9D43-6B89CCEF2735
wdt:P4844
wd:Q167934 wd:Q408471 wd:Q59488357 wd:Q186242
p:P2899
wds:Q63337348-BCD8B72D-1314-4206-B40B-599B58C0F088
wdt:P2899
18
p:P1132
wds:Q63337348-2DD20A07-004D-4AF4-90A9-23AC38F864B0
wdt:P1132
342
p:P4135
wds:Q63337348-D843CBD4-0115-491C-950D-B7B016AF5845
wdt:P4135
65
p:P8363
wds:Q63337348-DBF2073F-6386-4835-AE7D-22E8E457A772
wdt:P8363
wd:Q78089383
p:P3098
wds:Q63337348-36F90077-FF3C-49A7-959A-22239D3E9DD2
wdt:P3098
NCT01318434
p:P6099
wds:Q63337348-AD0CD1BD-6BB7-4A91-913C-CBB6DBC8C81D wds:Q63337348-6A630F79-5DA6-4B01-80E9-952119179DD0
wdt:P6099
wd:Q42824827 wd:Q42824440